Linked Life Data

7630616

Source:http://linkedlifedata.com/resource/pubmed/id/7630616

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
3
pubmed:dateCreated
1995-9-7
pubmed:abstractText
Colour Doppler imaging is a recent advance in ultrasonography. It allows simultaneous two-dimensional imaging of structures and evaluation of blood flow. Retinal vascular pathologies, macular degeneration, endobulbar tumours, and ischaemic vascular diseases can be analyzed by colour Doppler imaging. Moreover, it offers the possibility of evaluating the vascular effects of a drug and to monitor them in time. We have, therefore, carried out a study using colour Doppler imaging to evaluate a drug capable of acting on the vascular wall in patients with macular degeneration or diabetic retinopathy. The results show that this drug, obtained by enzymatic hydrolysis of bovine factor VIII (Vueffe; Laboratory Baldacci S.p.A., Pisa, Italy), induces a significant increase in blood flow and in retinal central artery systolic speed.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:issn
0030-3755
pubmed:author
pubmed:issnType
Print
pubmed:volume
209
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
117-21
pubmed:dateRevised
2007-9-17
pubmed:meshHeading
pubmed:year
1995
pubmed:articleTitle
Colour Doppler imaging to evaluate the action of a drug in ocular pathology.
pubmed:affiliation
Italian Centre for Medical Ultrasonic Diagnostics (CIDIMU) s.r.l., Turin.
pubmed:publicationType
Journal Article